3Kiopprl G,Perren A,Heitz PU.The gastroenteropancreatic neuroendocrine cell system and its tumors:the WHo classifu-cation[J].Anticancer Res,2000,20:2819-2854.
4Birkendamp-Demtr der K,Wagner L,Brandt S,et al,Secretagogin is a novel marker for neroendocrine differentiation[J].Neuroendocrinolgy,2005,82(2):121-138.
5Helpap B,Kollermauu J.lmmuuohistochemical analysis of the proliferative activity of neuroeudocriue tumors from various organs. Are there indications for a neuroeudocriue tumor-carcinoma sequence[J].Virchows Arch, 200i ,458:86 91.
7Blumenfeld W.Chandhoke DK,Sagerman P,et aI.Neuroendocrine dffferentiation in gastric adenocarcinomas. An immunohistochemical study[J].Arch Pathol Lab Meal,1996,120(5):478-481.
8Hamilton SR,Aaltonen LA.Pathology and genetics of tumours of the digestive system[A].World Health Organization classification of tumours[C].Lyon:IARCP,2000.
9Rindi G, Luinetti O, Cornaggia M. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocfine carcinoma: a clinicopathologic study[J]. Gastxoenterol, 1993,104(4) :994 - 1 006.
10Rindi G,Azzoni C,Rosa SL, et al .ECL cell tumor and poorly differentiated endocine carcinoma of the stomach: prognostic evaluation bypathological analysis[J]. Gastroenterol, 1999,166(3) :532 - 542.
